StockData

Community Health Systems vs Encompass Health

CYH and EHC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CYH and EHC compare

Encompass Health is the larger company, worth 49 times as much as Community Health Systems ($14.0B against $285M).

On earnings, Community Health Systems is cheaper: it trades at 7.8× trailing earnings, against 23.1× for Encompass Health.

Encompass Health grew revenue faster over the last twelve months (9.5% versus −7.8% for Community Health Systems).

Encompass Health keeps more of each dollar of sales as profit, with a net margin of 10.0% compared with 0.31% at Community Health Systems.

Encompass Health pays a dividend yielding 0.55%; Community Health Systems does not pay one.

Encompass Health scores higher on the StockData Score (16 against 8 for Community Health Systems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCYHEHC
Size and price
Market cap$285M$14.0B
Share price$2.02$142.11
Change, 1 year−38.0%24.4%
Change, 5 years−84.3%132%
Beta (5Y)1.500.55
Employees57K42K
StockData Score
Total score816 (better)
Valuation score3 (better)1
Growth score24 (better)
Performance score25 (better)
Health score13 (better)
Dividend score03 (better)
Valuation
P/E7.8× (better)23.1×
P/S0.0× (better)2.3×
P/B–5.4×
EV/EBITDA5.8× (better)11.6×
P/FCF–33.9×
PEG0.06 (better)0.85
FCF yield−42.8%2.9% (better)
Fair value–$128.88
Margin of safety–−10.3%
Growth
Revenue growth (TTM)−7.8%9.5% (better)
Revenue growth, 5Y average1.2%10.7% (better)
Net income growth (TTM)−89.1%18.8% (better)
EPS growth (TTM)−89.3%20.2% (better)
EPS growth, 5Y average−3.0%14.2% (better)
Profitability
Gross margin85.5%–
Operating margin10.9%–
Net margin0.31%10.0% (better)
FCF margin−1.0%6.7% (better)
Return on equity–25.5%
Return on invested capital7.5%–
Financial health
Debt / equity–1.01
Net debt / EBITDA5.541.68 (better)
Current ratio1.48 (better)1.19
Altman Z-score1.002.96 (better)
Piotroski F-score88
Dividends and buybacks
Dividend yield–0.55%
Payout ratio–12.1%
Years of dividend growth–2
Dividend growth, 5Y average–−8.5%
Buyback yield–1.8%
Shareholder yield0.00%2.3% (better)
Ownership
Held by institutions82.7%97.0%
Held by insiders9.0%1.0%
Insider net buying, 12 months−$118K (better)−$47.8M
Short interest, % of float9.8%3.7%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.